tm logo

Monitor this mark

View On USPTO

RESTASIS
Live/Registered
REGISTERED AND RENEWED

on 14 Feb 2023

Last Applicant/ Owned by

Allergan, Inc.

1 N. Waukegan Road

North Chicago

IL

60064

Serial Number

78041554 filed on 03rd Jan 2001

Registration Number

2738873 registered on 15th Jul 2003

in the Principal Register

Correspondent Address

Cheryl A. Withycombe

Cheryl A. Withycombe

18655 Teller Avenue

Mail code: AND-250C

IRVINE, CA 60064

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

RESTASIS

Topical ophthalmic pharmaceutical products for the treatment of dryness of the eye

Classification Information

Class [005]
Pharmaceutical Products

Topical ophthalmic pharmaceutical products for the treatment of dryness of the eye

First Use Date in General

29th Oct 1997

First Use Date in Commerce

01st Apr 2003

Mark Details

Serial Number

No 78041554

Mark Type

No Service/Collective Mark

Attorney Docket Number

No RESTASIS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
14th Feb 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
14th Feb 2023REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
14th Feb 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13th Feb 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27th Jul 2022TEAS SECTION 8 & 9 RECEIVED
15th Jul 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
23rd Feb 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
22nd Feb 2013REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
22nd Feb 2013REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
22nd Feb 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL